Search results

ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week.  Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.​

Applications on the Quokka instrument at ANSTO.

ARPANSA has given ANSTO approval to begin testing the neutron reflectometer, Spatz

Research to determine the potential dose from long- lived radioactive substances at mining, legacy sites and nuclear facilities.

System includes a vibrating-sample magnetometer, AC susceptibility, heat capacity and resistivity measurement capability.  

Insights into the behaviour of structural materials in a molten salt environment

Ancient groundwater in Australia contributing carbon to food webs through surface water.

Synchrotron technique clarifies the location of calcium in a promising material with a relatively high superconducting transition temperature.

Nuclear engineer, Robert Mardus-Hall, with his research partner Andrew Pastrello, are developing nuclear power based solutions for space missions to the Moon and Mars.

Scientists from Monash, ANSTo and China have developed an ultra-thin membrane that could separate harmful ions from water or capture gases.

Potential new treatments and tools for depression under development.

Modifications to promising novel non-fullerene small molecule acceptor in organic thin film for solar cells demonstrates improved power conversion efficiency.

Specifications, Beryllium Filter, User Manual, Instrument reference